This content is machine translated Hidradenitis suppurativa/acne inversa Relieving suffering and inflammation – how can this be achieved? Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling...…
View Post 4 min This content is machine translated Inflammatory memory in psoriasis Timing of biologics therapy is crucial The pathogenesis of psoriasis is complex, but is becoming increasingly better understood. With the modern substance classes of interleukin (IL)-17 and IL-23 inhibitors, highly effective biologics are now available for…
View Post 9 min This content is machine translated System therapy for psoriasis Expanded possibilities thanks to practical innovations Compared to the past, there are now more and more effective systemic therapies available. This has been helped by a surge in innovation that has produced a wide range of…
View Post 18 min This content is machine translated Hidradenitis suppurativa/acne inversa Challenges of outpatient care The disease hidradenitis suppurativa/acne inversa was first mentioned in 1839 with superficial abscesses on the axillary, submammary and perianal regions. To date, the disease has had various names: Perifolliculitis capitis… CME-Test
View Post 5 min This content is machine translated Biologics therapy for psoriasis Better outcomes through innovative methods of therapy management Personalized medicine is also becoming increasingly important in the field of inflammatory skin diseases. Currently, IL-17 and IL-23 inhibitors are most effective in moderate to severe psoriasis, but the response…
View Post 15 min This content is machine translated Hidradenitis suppurativa Etiopathogenesis, diagnosis and treatment – an update The pathogenesis of hidradenitis suppurativa (HS) has not yet been fully clarified; it is assumed that there are multifactorial interactions. The most important risk factors and comorbidities include smoking, obesity… CME-Test
View Post 8 min This content is machine translated Psoriasis vulgaris Practice-oriented recommendations for system therapy Fortunately, developments in recent years have led to the effective treatment of many patients with moderate to severe psoriasis. In addition to classical immunosuppressants, several biologics and a small molecule…
View Post 3 min This content is machine translated Plaque psoriasis Current 5-year data on secukinumab A long-term extension analysis of the ERASURE and FIXTURE studies recently published in the British Journal of Dermatology demonstrates the long-lasting efficacy and safety of secukinumab in patients with moderate-to-severe…
View Post 4 min This content is machine translated Biologics for psoriasis “Drug Survival” under the microscope The era of biologics has revolutionized the treatment options for patients with moderate to severe psoriasis in recent decades. Drug survival is an indicator of the longer-term efficacy and safety…
View Post 8 min This content is machine translated Plaque psoriasis Updated guideline recommendations for children and adolescents Early treatment in children and adolescents with psoriasis is an important supply target. The updated s2k guideline provides evidence-based decision support for the selection of appropriate therapy. In the new edition…
View Post 4 min This content is machine translated Psoriasis and psoriatic arthritis Secukinumab as a treatment option in pediatric patients – an update. Children and adolescents affected by psoriasis and/or psoriatic arthritis often suffer a great deal. Particularly in cases of severe symptoms, the quality of life of those affected and their families…
